Skip to content

Clinical trials

Phase 3 Dementia trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Dementia Phase: Phase 3 Clear all

108 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20004
20018
20023
20038
20042
20052
20063
20072
20087
20092
20103
20114
20123
20136
20145
20154
20163
20174
20183
20201
20226
20235
20242
20255
20263

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed66
Terminated20
Active, not recruiting8
Recruiting8
Unknown status4
Withdrawn2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.10
Eli Lilly and Company5
Novartis4
Otsuka Pharmaceutical Development & Commercialization, Inc.4
AstraZeneca3
Bristol-Myers Squibb3
Eisai Co., Ltd.3
FORUM Pharmaceuticals Inc3
Myrexis Inc.3
National Center for Complementary and Integrative Health (NCCIH)3

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Dementia108
Alzheimer Disease82
Cognitive Dysfunction27
Mental Disorders16
Brain Diseases15
Memory Disorders14
Neurodegenerative Diseases14
Nervous System Diseases13
Psychomotor Agitation12
Dementia, Vascular10

Trials

Showing 26 to 50 of 108. Each trial links to its page on Pharma Observatory.

8 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.